
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Parexel International Corporation, a global biopharmaceutical services organization, announced it will collaborate with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials.
Read the full release






